GlaxoSmithKline PLC Blocklisting Application (1322X)
17 Dicembre 2019 - 10:00AM
UK Regulatory
TIDMGSK
RNS Number : 1322X
GlaxoSmithKline PLC
17 December 2019
GlaxoSmithKline plc
Blocklisting Application
Application has been made to the Financial Conduct Authority and
the London Stock Exchange plc for a total of 370,000 Ordinary
Shares of 25p each ('Shares') to be admitted to the Official
List.
The Shares are being reserved under an existing blocklisting and
will be issued under the GlaxoSmithKline plc 2009 Deferred Annual
Bonus Plan.
When issued, the Shares will rank pari passu with the existing
Ordinary Shares of 25p each.
Admission is expected to be effective on 18 December 2019.
Victoria Whyte
Company Secretary
17 December 2019
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
ALSLIFSTFLLDLIA
(END) Dow Jones Newswires
December 17, 2019 04:00 ET (09:00 GMT)
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Apr 2023 a Apr 2024